ClinSync Clinical Research Pvt Ltd

Hyderabad, Telangana

Handling incoming and outgoing calls.Should attend to a visitor or customer present physically at office.Should responsible for providing information about the services and products of the organization.Receive letters, couriers etc. and distribute them.Keeping the reception area tidy and observing professional etiquette.Performing other administrative tasks, if required.

1.Prepare, conduct and report on activities related to the completion of site selection, initiation, routine monitoring and close-out visits2.Monitor patient enrollment to ensure recruitment targets and project timelines are met at the site and/or country level3.Perform source data verification and follow up on data queries at the site level, on-going review of any 4.Risk Based Monitoring related information influencing data quality and frequency of site visits5.Ensure accurate and timely reporting and follow up of Adverse Events (AE)/Serious Adverse Events (SAE) and protocol deviations6.Act as the main line of communication between the Sponsor and the site.7.Be a point of contact/liaison for in-house support services and vendors.8.Ensure proper handling, accountability and reconciliation of all Investigational Product(s) and clinical study supplies9.Review the status and contents of essential documents at the site level and reconcile study OSF/ TMF at site and/or country level.10.Experience in all types of monitoring visits.

1. The investigator shall be responsible for the conduct of the trial according to the protocol and the Good Clinical Practices Guidelines, Ethical guidelines and also for compliance as per the undertaking (PIU) and Standard operating procedures.2. The investigator is responsible for supervising any individual to whom the investigator delegates trial-related duties and functions conducted at the trial site.3. The investigator is responsible for reviewing, and approving the protocol, prior to the ethics committee approval.4. During and following trial a subjects participation in trial, the investigator should ensure that adequate medical care is provided to the participant for any adverse events 5. Protection of the Trial Subject.